Therapeutic targets in rheumatoid arthritis: More to come but which one(s) to select?

Drug Discovery Today: Disease Mechanisms

Volumn 2, Issue 3, 2005, Pages 327-330

  Miossec, Pierre ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; CD20 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 18; MESSENGER RNA; METHOTREXATE; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANTIGEN PRESENTING CELL; CELL INTERACTION; CELL MATURATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFICACY; DRUG RESPONSE; DRUG TARGETING; HUMAN; LYMPHOCYTE FUNCTION; NONHUMAN; PATHOGENESIS; PHENOTYPE; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

EID: 33645087915     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2005.08.008     Document Type: Review

References (20)

1. M. Feldmann et. al. The transfer of a laboratory-based hypothesis to a clinically useful therapy: The development of anti-TNF therapy of rheumatoid arthritis Best Pract. Res. Clin. Rheumatol. 18 2004 59-80
2. W.P. Arend J.M. Dayer Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis Arthritis Rheum. 33 1990 305-315
3. F.M. Brennan et. al. Inhibitory effect of TNF-alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis Lancet 2 1989 244-247
4. M.J. Elliott et. al. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis Lancet 344 1994 1105-1110
5. J.S. Smolen et. al. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study Arthritis Rheum. 52 2005 1020-1030
6. P. Miossec IL-17 in rheumatoid arthritis: A new target for treatment or just another cytokine? Joint Bone Spine 71 2004 87-90
7. C. Granet et. al. Increased AP-1 and NF-kappaB activation and recruitment with the combination of the proinflammatory cytokines IL-1beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes Arthritis Res. Ther. 6 2004 R190-R198
8. I.B. McInnes et. al. Interleukin-18: A therapeutic target in rheumatoid arthritis? Arthritis Res. Ther. 7 2005 38-41
9. R.L. Smeets et. al. Adenoviral delivery of IL-18 binding protein C ameliorates collagen-induced arthritis in mice Gene Ther. 10 2003 1004-1011
10. M. Chabaud et. al. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by rheumatoid synovium Arthritis Rheum. 42 1999 963-970
11. E. Lubberts et. al. The role of T cell interleukin-17 in conducting destructive arthritis: Lessons from animal models Arthritis Res. Ther. 7 2005 29-37
12. J.J. Haringman P.P. Tak Chemokine blockade: A new era in the treatment of rheumatoid arthritis? Arthritis Res. Ther. 6 2004 93-97
13. G. Page P. Miossec Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression J. Pathol. 204 2004 28-38
14. J.M. Kremer et. al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig N. Engl. J. Med. 349 2003 1907-1915
15. B. Coiffier et. al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma N. Engl. J. Med. 346 2002 235-242
16. J.C. Edwards et. al. Efficacy of B cell-targeted therapy with rituximab in patients with rheumatoid arthritis N. Engl. J. Med. 350 2004 2572-2581
17. L.F. Bovin et. al. Blood cell gene expression profiling in rheumatoid arthritis. Discriminative genes and effect of rheumatoid factor Immunol. Lett. 93 2004 217-226
18. M. Rihl et. al. Technical validation of cDNA-based microarray as screening technique to identify candidate genes in synovial tissue biopsy specimens from patients with spondyloarthropathy Ann. Rheum. Dis. 63 2004 498-507
19. P. Miossec W. van den Berg Th1/Th2 cytokine balance in arthritis Arthritis Rheum. 40 1997 2105-2115
20. M.R. Ehrenstein et. al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF-alpha therapy J. Exp. Med. 200 2004 277-285